Diabetes breakthrough? weekly drug may end carb counting for type 1 patients
NCT ID NCT07284511
First seen Dec 18, 2025 · Last updated May 02, 2026 · Updated 20 times
Summary
This study tests if tirzepatide, a weekly medication for type 2 diabetes, can help adults with type 1 diabetes use an automated insulin pump without counting carbohydrates at meals. About 105 participants in Canada and Switzerland will either receive tirzepatide plus the pump or continue standard care. The goal is to see if tirzepatide can safely maintain good blood sugar control while reducing daily diabetes burden.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Insel Hospital, University Hospital Bern
Bern, 3010, Switzerland
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Institut de Recherches Cliniques de Montréal
Montreal, Quebec, H2W 1R7, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
McGill University Health Centre
Montreal, Quebec, H4A 3J1, Canada
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.